DE69723845D1 - Therapien des chronischen nierenversagens - Google Patents
Therapien des chronischen nierenversagensInfo
- Publication number
- DE69723845D1 DE69723845D1 DE69723845T DE69723845T DE69723845D1 DE 69723845 D1 DE69723845 D1 DE 69723845D1 DE 69723845 T DE69723845 T DE 69723845T DE 69723845 T DE69723845 T DE 69723845T DE 69723845 D1 DE69723845 D1 DE 69723845D1
- Authority
- DE
- Germany
- Prior art keywords
- therapies
- chronic kidney
- kidney failure
- risk
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/643,321 US6498142B1 (en) | 1996-05-06 | 1996-05-06 | Morphogen treatment for chronic renal failure |
US643321 | 1996-05-06 | ||
PCT/US1997/007655 WO1997041880A1 (en) | 1996-05-06 | 1997-05-06 | Therapies for chronic renal failure |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69723845D1 true DE69723845D1 (de) | 2003-09-04 |
DE69723845T2 DE69723845T2 (de) | 2004-06-03 |
Family
ID=24580305
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69723845T Expired - Lifetime DE69723845T2 (de) | 1996-05-06 | 1997-05-06 | Therapien des chronischen nierenversagens |
DE69730966T Expired - Lifetime DE69730966T2 (de) | 1996-05-06 | 1997-05-06 | Morphogenische behandlung des chronischen nierenversagens |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69730966T Expired - Lifetime DE69730966T2 (de) | 1996-05-06 | 1997-05-06 | Morphogenische behandlung des chronischen nierenversagens |
Country Status (11)
Country | Link |
---|---|
US (5) | US6498142B1 (de) |
EP (2) | EP0910400B1 (de) |
JP (4) | JP4766722B2 (de) |
AT (2) | ATE245997T1 (de) |
AU (2) | AU2933997A (de) |
CA (2) | CA2254954C (de) |
DE (2) | DE69723845T2 (de) |
DK (2) | DK0910400T3 (de) |
ES (2) | ES2203803T3 (de) |
PT (2) | PT914146E (de) |
WO (2) | WO1997041881A1 (de) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6077823A (en) * | 1991-03-11 | 2000-06-20 | Creative Biomolecules, Inc. | Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury |
CA2363965C (en) * | 1991-03-11 | 2010-05-18 | Curis, Inc. | Protein-induced morphogenesis |
US20030167492A1 (en) | 1994-07-08 | 2003-09-04 | Johns Hopkins University School Of Medicine | Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same |
US6498142B1 (en) | 1996-05-06 | 2002-12-24 | Curis, Inc. | Morphogen treatment for chronic renal failure |
EP0980252B1 (de) * | 1997-05-05 | 2004-10-06 | Curis, Inc. | Therapien zur behandlung von akutem nierenversagen |
AU7473098A (en) * | 1997-05-07 | 1998-11-27 | Biogen, Inc. | Novel therapies for cystic kidney disease |
EP0896825B1 (de) | 1997-08-14 | 2002-07-17 | Sulzer Innotec Ag | Zusammensetzung und Vorrichtung zur Reparatur von Knorpelgewebe in vivo bestehend aus Nanokapseln mit osteoinduktiven und/oder chondroinduktiven Faktoren |
US6203788B1 (en) * | 1997-09-29 | 2001-03-20 | Adherex Inc. | Compounds and methods for regulating cell adhesion |
AU1706499A (en) * | 1997-12-04 | 1999-06-16 | Curis, Inc. | Maintenance of smooth muscle integrity by morphogenic proteins |
NZ509609A (en) * | 1998-07-28 | 2003-11-28 | Univ Johns Hopkins Med | Disrupting growth differentiation factor-11 (GDF-11) to increase the muscle and bone tissue in animals |
US6992066B2 (en) * | 1998-10-16 | 2006-01-31 | Zimmer Orthobiologics, Inc. | Povidone-containing carriers for polypeptide growth factors |
US7087577B2 (en) * | 1998-10-16 | 2006-08-08 | Zimmer Orthobiologies, Inc. | Method of promoting natural bypass |
DE60027907T2 (de) * | 1999-09-14 | 2007-01-04 | Biogen Idec Ma Inc., Cambridge | Therapien für chronische niereninsuffizienz unter verwendung von ein oder mehreren integrinantagonist(en) |
US20020173453A1 (en) * | 2000-12-15 | 2002-11-21 | Rama Akella | Method of treating renal injury |
US7763769B2 (en) | 2001-02-16 | 2010-07-27 | Kci Licensing, Inc. | Biocompatible wound dressing |
US7700819B2 (en) | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
US7232802B2 (en) * | 2001-12-21 | 2007-06-19 | Zimmer Orthobiologics, Inc. | Compositions and methods for promoting myocardial and peripheral angiogenesis |
US7622562B2 (en) | 2002-06-26 | 2009-11-24 | Zimmer Orthobiologics, Inc. | Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue |
WO2004019876A2 (en) * | 2002-08-28 | 2004-03-11 | Curis, Inc. | Conjoint administration of morphogens and ace inhibitors in treatment of chronic renal failure |
EP1677735B1 (de) | 2003-10-17 | 2014-07-23 | Joslin Diabetes Center, Inc. | Verfahren und zusammensetzungen zur modulierung der adipozyten-funktion |
US7844367B2 (en) | 2003-12-23 | 2010-11-30 | Rain Bird Corporation | Code replacement for irrigation controllers |
WO2005094384A2 (en) | 2004-03-30 | 2005-10-13 | Ilypsa, Inc. | Methods and compositions for treatment of ion imbalances |
US7459527B2 (en) * | 2004-03-31 | 2008-12-02 | Xencor, Inc. | BMP-7 variants with improved properties |
WO2006130690A2 (en) | 2005-06-01 | 2006-12-07 | Joslin Diabetes Center, Inc. | Methods and compositions for inducing brown adipogenesis |
US7771995B2 (en) * | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
EP1951751B1 (de) * | 2005-11-14 | 2017-11-01 | Merial, Inc. | Gentherapie bei nierenversagen |
US20090004159A1 (en) * | 2006-01-24 | 2009-01-01 | The Board Of Trustees Of The University Of Illinoi | Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells |
WO2008021577A2 (en) | 2006-01-24 | 2008-02-21 | The Board Of Trustees Of The University Of Illinois | Polymerized hemoglobin media and its use in isolation and transplantation of islet cells |
US20080090765A1 (en) * | 2006-05-25 | 2008-04-17 | The Trustees Of Columbia University In The City Of New York | Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage |
EP2035835B1 (de) | 2006-05-30 | 2011-12-28 | Antibodyshop A/S | Verfahren zur schnellen beurteilung der schwere eines traumas |
US7722665B2 (en) | 2006-07-07 | 2010-05-25 | Graft Technologies, Inc. | System and method for providing a graft in a vascular environment |
JP5175729B2 (ja) | 2006-07-21 | 2013-04-03 | 中外製薬株式会社 | 腎疾患治療剤 |
EP2114390A2 (de) * | 2006-12-15 | 2009-11-11 | Ruprecht-Karls-Universität Heidelberg | Verfahren zur behandlung von erkrankungen im zusammenhang mit podozyten |
AU2008245900B2 (en) * | 2007-04-24 | 2013-07-25 | Advanced Technologies And Regenerative Medicine, Llc | Engineered renal tissue |
DE102007034580B4 (de) * | 2007-07-13 | 2012-11-08 | NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen | Biomaterial basierend auf einem hydrophilen polymeren Träger |
US20090155245A1 (en) * | 2007-12-18 | 2009-06-18 | Fang Carrie H | Treatment for Organ Regeneration with Combination of Drug and Biologics |
EP2283119B1 (de) * | 2008-05-06 | 2015-01-07 | Joslin Diabetes Center, Inc. | Verfahren und zusammensetzungen zur einleitung von brauner adipogenese |
WO2009157165A1 (ja) * | 2008-06-24 | 2009-12-30 | 株式会社根本杏林堂 | 薬液注入装置、この薬液注入装置を有する透視撮像システム、薬液注入装置のコンピュータプログラムおよびデータ処理方法 |
NZ610356A (en) * | 2008-08-28 | 2015-03-27 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
WO2010025434A1 (en) * | 2008-08-29 | 2010-03-04 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CN104399089B (zh) | 2008-10-21 | 2017-04-19 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
EP2767833A3 (de) * | 2008-10-21 | 2014-12-17 | Astute Medical, Inc. | Verfahren und Zusammensetzungen zur Diagnose und Prognose von Nierenläsion und Niereninsuffizienz |
NZ592488A (en) | 2008-11-10 | 2012-10-26 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CN104034901A (zh) * | 2008-11-22 | 2014-09-10 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
US9229010B2 (en) | 2009-02-06 | 2016-01-05 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CN104111336B (zh) * | 2009-02-06 | 2017-01-18 | 阿斯图特医药公司 | 肾损伤和肾衰竭的诊断及预后 |
JP5819734B2 (ja) | 2009-02-12 | 2015-11-24 | ストライカー コーポレイションStryker Corporation | TGF−βスーパーファミリーメンバー含有タンパク質の最小に侵襲性の全身送達のための組成物および方法 |
CA2752157A1 (en) * | 2009-02-12 | 2010-08-19 | Stryker Corporation | Peripheral administration of proteins including tgf-.beta. superfamily members for systemic treatment of disorders and disease |
EP2406281B1 (de) | 2009-03-12 | 2016-02-17 | Haase Investments UG | Varianten des knochenmorphogenetischen proteins 2 (bone morphogenetic protein 2, bmp2) mit reduzierter bmp-antagonistischer empfindlichkeit |
WO2010144696A1 (en) | 2009-06-11 | 2010-12-16 | Burnham Institute For Medical Research | Directed differentiation of stem cells |
NZ598034A (en) | 2009-08-07 | 2014-06-27 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
ES2387379T3 (es) | 2009-09-17 | 2012-09-21 | Stryker Corporation | Tampones para controlar el pH de las proteínas morfogenéticas óseas |
WO2011057147A1 (en) | 2009-11-07 | 2011-05-12 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
MX342967B (es) | 2009-12-20 | 2016-10-19 | Astute Medical Inc | Metodos y composiciones para la diagnosis y prognosis de lesion renal y falla renal. |
EP2516456A1 (de) | 2009-12-22 | 2012-10-31 | Stryker Corporation | Bmp-7-varianten mit reduzierter immunogenität |
JP2013519095A (ja) | 2010-02-05 | 2013-05-23 | アスチュート メディカル,インコーポレイテッド | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
KR20140051754A (ko) | 2010-02-26 | 2014-05-02 | 아스튜트 메디컬 인코포레이티드 | 신장 손상 및 신부전의 진단 및 예후를 위한 방법 및 조성물 |
JP2013529907A (ja) | 2010-05-24 | 2013-07-25 | ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク | Ngalタンパク質変異体及びその使用 |
WO2011162821A1 (en) | 2010-06-23 | 2011-12-29 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
NZ703055A (en) | 2010-06-23 | 2016-07-29 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
PE20140135A1 (es) | 2010-08-20 | 2014-02-20 | Wyeth Llc | Proteina osteogenicas de diseno |
US9688735B2 (en) | 2010-08-20 | 2017-06-27 | Wyeth Llc | Designer osteogenic proteins |
US10935548B2 (en) | 2011-12-08 | 2021-03-02 | Astute Medical, Inc. | Methods for diagnosis and prognosis of renal injury and renal failure using insulin-like growth factor-binding protein 7 and metalloproteinase inhibitor 2 |
CN104822383A (zh) | 2012-10-08 | 2015-08-05 | 瑞立普萨公司 | 治疗高血压和高血钾症的钾结合剂 |
EP2925337B1 (de) | 2012-11-21 | 2019-07-03 | The Trustees of Columbia University in the City of New York | Mutante ngal-proteine und verwendungen davon |
AU2014207509B2 (en) | 2013-01-17 | 2019-12-12 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US8956829B2 (en) | 2013-01-25 | 2015-02-17 | Warsaw Orthopedic, Inc. | Human recombinant growth and differentiaton factor-5 (rhGDF-5) |
US9169308B2 (en) | 2013-01-25 | 2015-10-27 | Warsaw Orthopedic, Inc. | Methods and compositions of human recombinant growth and differentiation factor-5 (rhGDF-5) isolated from inclusion bodies |
US9051389B2 (en) | 2013-01-25 | 2015-06-09 | Warsaw Orthopedic, Inc. | Expression conditions and methods of human recombinant growth and differentiation factor-5 (rhGDF-5) |
US9359417B2 (en) | 2013-01-25 | 2016-06-07 | Warsaw Orthopedic, Inc. | Cell cultures and methods of human recombinant growth and differentiaton factor-5 (rhGDF-5) |
US8945872B2 (en) | 2013-01-25 | 2015-02-03 | Warsaw Orthopedic, Inc. | Methods of purifying human recombinant growth and differentiation factor-5 (rhGDF-5) protein |
EP2784083A1 (de) | 2013-03-28 | 2014-10-01 | Charité - Universitätsmedizin Berlin | Knochenmorphogenetische Protein (BMP)-Varianten mit hoch reduzierter Antagonisten-Sensibilität und erweiterter spezifischer biologischer Aktivität |
US10539588B2 (en) * | 2013-11-11 | 2020-01-21 | General Electric Company | Method for reducing error in rotor speed measurements |
EP2944326B1 (de) | 2014-05-16 | 2018-11-21 | Cyanagen Srl | Tricarbocyanin-cyclodextrin-konjugate und deren verwendung zur diagnose von nierenkrankheiten |
JP7199809B2 (ja) | 2015-02-13 | 2023-01-06 | ファクター バイオサイエンス インコーポレイテッド | 核酸製品及びその投与方法 |
EP3465201A4 (de) | 2016-06-06 | 2020-08-26 | Astute Medical, Inc. | Verwaltung von akuter nierenverletzung mit insulinähnlichem wachstumsfaktorbindendem protein 7 und gewebehemmer der metalloproteinase 2 |
WO2018035377A1 (en) | 2016-08-17 | 2018-02-22 | Factor Bioscience Inc. | Nucleic acid products and methods of administration thereof |
JP2019039673A (ja) * | 2017-08-22 | 2019-03-14 | セイコーエプソン株式会社 | 時間デジタル変換回路、回路装置、物理量測定装置、電子機器及び移動体 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1156741B (it) * | 1978-05-15 | 1987-02-04 | Sigma Tau Ind Farmaceuti | Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi |
US4342828A (en) | 1979-07-20 | 1982-08-03 | Morinaga Milk Industry Co., Ltd. | Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells |
US4627839A (en) | 1985-11-21 | 1986-12-09 | American Hospital Supply Corporation | Patient controlled analgesia conversion |
IL83003A (en) | 1986-07-01 | 1995-07-31 | Genetics Inst | Factors that soak bone formation |
US5013649A (en) * | 1986-07-01 | 1991-05-07 | Genetics Institute, Inc. | DNA sequences encoding osteoinductive products |
US5266683A (en) * | 1988-04-08 | 1993-11-30 | Stryker Corporation | Osteogenic proteins |
US5011691A (en) * | 1988-08-15 | 1991-04-30 | Stryker Corporation | Osteogenic devices |
US5045452A (en) * | 1988-09-02 | 1991-09-03 | Brigham And Women's Hospital | Method for evaluating nephrotoxicity |
ATE162223T1 (de) | 1989-03-28 | 1998-01-15 | Genetics Inst | Osteoinduktive zusammensetzungen |
EP0536186B1 (de) | 1990-05-16 | 2001-11-21 | Genetics Institute, Inc. | Knochen- und knorpel-bildung hervorrufende proteine |
JPH0426624A (ja) * | 1990-05-18 | 1992-01-29 | Tsumura & Co | 慢性腎不全改善剤 |
EP0533840B1 (de) | 1990-06-22 | 1996-12-11 | E.I. Du Pont De Nemours And Company | Behandlung des chronischen nierenversagens mit imidazol-angiotensin-ii-rezeptorantagonisten |
US7056882B2 (en) | 1991-03-11 | 2006-06-06 | Curis, Inc. | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
CA2363965C (en) | 1991-03-11 | 2010-05-18 | Curis, Inc. | Protein-induced morphogenesis |
US6194376B1 (en) | 1991-03-11 | 2001-02-27 | Creative Biomolecules, Inc. | Method for modulating inflammatory response comprising administering morphogen |
US6077823A (en) * | 1991-03-11 | 2000-06-20 | Creative Biomolecules, Inc. | Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury |
EP0575555B1 (de) | 1991-03-11 | 2001-07-18 | Curis, Inc. | Protein-induzierende morphogenese |
US5849686A (en) * | 1991-03-11 | 1998-12-15 | Creative Biomolecules, Inc. | Morphogen-induced liver regeneration |
US6287816B1 (en) | 1991-06-25 | 2001-09-11 | Genetics Institute, Inc. | BMP-9 compositions |
JP3693338B2 (ja) | 1991-08-30 | 2005-09-07 | キュリス インコーポレイテッド | 組織形成因子誘導による炎症反応の調節 |
CA2116560C (en) | 1991-08-30 | 2002-01-08 | Charles M. Cohen | Morphogenic protein screening method |
DE69233559T2 (de) | 1991-08-30 | 2006-08-31 | Curis, Inc., Cambridge | Osteogenische proteine in der behandlung von metabolischen knochenkrankheiten |
US6120760A (en) * | 1992-02-12 | 2000-09-19 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung | Growth/differentiation factors of the TGF-β family |
AU681594B2 (en) | 1992-07-31 | 1997-09-04 | Stryker Corporation | Morphogen-induced nerve regeneration and repair |
KR950702627A (ko) | 1992-07-31 | 1995-07-29 | 찰스 엠. 코헨 | 모르포겐 단백질의 가용성 복합체 및 그의 조성물(Morphogenic Protein Soluble Complex and Composition Thereof) |
ES2118253T3 (es) | 1992-07-31 | 1998-09-16 | Creative Biomolecules Inc | Composicion dietetica enriquecida con morfogen. |
AU681356B2 (en) | 1992-09-16 | 1997-08-28 | Stryker Corporation | Morphogen-induced liver regeneration |
JPH08503198A (ja) | 1992-11-03 | 1996-04-09 | クリエイティブ バイオモレキュルズ,インコーポレイテッド | Op−3誘導形態形成 |
US5372335A (en) | 1992-12-18 | 1994-12-13 | Scott H. Yenzer | Aerial marker ball and method of placement |
EP0687272B1 (de) | 1993-03-04 | 2007-01-17 | Stryker Corporation | Verfahren und zusammensetzungen zur herstellung von rekombinantem osteogenischem protein |
US5631159A (en) | 1993-09-22 | 1997-05-20 | Creative Biomolecules, Inc. | Lipid-modified serum free media |
US5585237A (en) | 1993-10-25 | 1996-12-17 | Creative Biomolecules, Inc. | Methods and compositions for high protein production from recombinant DNA |
CA2176709A1 (en) * | 1993-11-15 | 1995-05-26 | Howard R. Higley | Method of treating renal disease by administering igf-i and igfbp-3 |
US5525621A (en) * | 1994-05-20 | 1996-06-11 | Cytos Pharmaceuticals Llc | Imidazole derivatives as protective agents in reperfusion injury and severe inflammatory responses |
US5714511A (en) * | 1995-07-31 | 1998-02-03 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs |
US5723411A (en) * | 1995-10-31 | 1998-03-03 | E. I. Du Pont De Nemours And Company | Herbicidal pyridazinones |
US6407060B1 (en) | 1996-03-22 | 2002-06-18 | Curis, Inc. | Method for enhancing functional recovery following central nervous system ischemia or trauma |
US5820589A (en) | 1996-04-30 | 1998-10-13 | Medtronic, Inc. | Implantable non-invasive rate-adjustable pump |
US6498142B1 (en) * | 1996-05-06 | 2002-12-24 | Curis, Inc. | Morphogen treatment for chronic renal failure |
US5879908A (en) * | 1997-04-30 | 1999-03-09 | Smithkline Beecham Corporation | CRFG-1a, a target and marker for chronic renal failure |
US7147839B2 (en) * | 1998-05-29 | 2006-12-12 | Curis, Inc. | Methods for evaluating tissue morphogenesis and activity |
-
1996
- 1996-05-06 US US08/643,321 patent/US6498142B1/en not_active Expired - Lifetime
-
1997
- 1997-05-06 DE DE69723845T patent/DE69723845T2/de not_active Expired - Lifetime
- 1997-05-06 EP EP97923567A patent/EP0910400B1/de not_active Expired - Lifetime
- 1997-05-06 CA CA002254954A patent/CA2254954C/en not_active Expired - Fee Related
- 1997-05-06 DE DE69730966T patent/DE69730966T2/de not_active Expired - Lifetime
- 1997-05-06 US US08/851,628 patent/US6861404B1/en not_active Expired - Fee Related
- 1997-05-06 PT PT97922726T patent/PT914146E/pt unknown
- 1997-05-06 AU AU29339/97A patent/AU2933997A/en not_active Abandoned
- 1997-05-06 JP JP54021197A patent/JP4766722B2/ja not_active Expired - Fee Related
- 1997-05-06 WO PCT/US1997/007816 patent/WO1997041881A1/en active IP Right Grant
- 1997-05-06 AT AT97923567T patent/ATE245997T1/de not_active IP Right Cessation
- 1997-05-06 AT AT97922726T patent/ATE277629T1/de active
- 1997-05-06 DK DK97923567T patent/DK0910400T3/da active
- 1997-05-06 EP EP97922726A patent/EP0914146B1/de not_active Expired - Lifetime
- 1997-05-06 JP JP09540150A patent/JP2000510835A/ja active Pending
- 1997-05-06 AU AU28322/97A patent/AU2832297A/en not_active Abandoned
- 1997-05-06 ES ES97923567T patent/ES2203803T3/es not_active Expired - Lifetime
- 1997-05-06 PT PT97923567T patent/PT910400E/pt unknown
- 1997-05-06 WO PCT/US1997/007655 patent/WO1997041880A1/en active IP Right Grant
- 1997-05-06 ES ES97922726T patent/ES2230604T3/es not_active Expired - Lifetime
- 1997-05-06 CA CA002254953A patent/CA2254953C/en not_active Expired - Fee Related
- 1997-05-06 DK DK97922726T patent/DK0914146T3/da active
-
2004
- 2004-12-17 US US11/016,499 patent/US7524817B2/en not_active Expired - Fee Related
-
2009
- 2009-03-16 US US12/404,559 patent/US8017580B2/en not_active Expired - Fee Related
- 2009-05-26 JP JP2009126963A patent/JP5247593B2/ja not_active Expired - Fee Related
-
2011
- 2011-08-11 US US13/207,584 patent/US8377878B2/en not_active Expired - Fee Related
-
2012
- 2012-08-14 JP JP2012179876A patent/JP2012229268A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE245997T1 (de) | Therapien des chronischen nierenversagens | |
TR199802421T2 (xx) | Doku yenilenmesini d�zenleyen maddeler. | |
ATE278414T1 (de) | Therapien zur behandlung von akutem nierenversagen | |
DE69432582D1 (de) | System zur Administration von Flüssigkeiten bei mehreren Patienten | |
NO970536D0 (no) | Behandlingssystem for avgitt blod med skrå reguleringsgrenseflate | |
ATE411818T1 (de) | Rekombinantes,virales vektorsystem | |
NO982436D0 (no) | Apparat for oppvarming av blod | |
DK52089A (da) | Middel til behandling af nyresygdomme | |
RS20050035A (en) | Therapies for renal failure using interferon-betha | |
PL316449A1 (en) | Combinations of thrombolytically active proteins and coagulants and their application | |
DE69825625D1 (de) | Aminobiguanide und ihre verwendung zur desinfektion von kontaktlinsen und konservierung von pharmazeutischen zubereitungen | |
DE69714451T2 (de) | Prionbindende proteine und deren verwendungen | |
WO2004019876A3 (en) | Conjoint administration of morphogens and ace inhibitors in treatment of chronic renal failure | |
HUP9801214A2 (hu) | Lecitin-koleszterin acil-transzferázt kifejező rekombináns vírusok és génterápiában való felhasználásuk | |
ATE361756T1 (de) | Insulinartiger-wachstumsfaktorbindungsprotein-4 protease | |
NZ500216A (en) | Beta-amyloid peptide-binding proteins and pharmaceutical use | |
CY1105117T1 (el) | Θepαπειες για τη χρονια νεφρικη ανεπαρκεια χρησιμοποιωντας ανταγωνιστες των ενσωματινων | |
BR9713514A (pt) | Novo uso de creatina | |
DK0653939T3 (da) | Anvendelse af en Hymenoptera-gift til fremstilling af et medikament til behandling af DNA-virusinfektioner | |
DK0495226T3 (da) | Anvendelse af 3-aryl-5-alkylthio-4H-1,2,4-triazoler til behandling af hyperrefleksi som følge af spinaltrauma | |
ATE204169T1 (de) | Polyamin-antagonisten enthaltende intraokulare irrigationslösung | |
PT999849E (pt) | Utilizacao de lbp no tratamento da septicemia | |
XJHuang | Placental Intravenous Immunoglobulin (PtIVIG) for Treatment of Chronic Graft Versus Host Disease (CGVHD) | |
DE59609353D1 (de) | Mittel zur subkutanen Verabreichung von Protein C | |
UA29043A (uk) | Спосіб визначення коагуляційної активності гемолізаткальцієвої суміші |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: STRYKER CORP., KALAMAZOO, MICH., US |
|
8328 | Change in the person/name/address of the agent |
Representative=s name: LICHTI PATENTANWAELTE, 76227 KARLSRUHE |